Liminatus Pharma, Inc. — Form D

Liminatus Pharma, Inc. of FULLERTON, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-06-18. The offering totals $1.9M, of which $1.9M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2026-06-18
• Form: D
• Accession: 0001104659-26-075732
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $1.9M
• Amount sold: $1.9M
• Investors: 1
• Revenue range: Decline to Disclose
• SEC file number: 021-587962

Issuer

• Name: Liminatus Pharma, Inc.
• CIK: 0001971387
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 2251 STERN GOODMAN STREET, SUITE E 16TH FLOOR, FULLERTON, CA, 92833
• Phone: 213-273-5453

Officers, directors & promoters (8)

More

• CIK 1971387 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search